Additionally, other VHL targets including estrogen receptor α (ERα), Extracellular signal-regulated kinase 5 (ERK5) and Kruppel-like factor 4 (KLF4) have been identified to rationalize the multiple symptoms exhibited in VHL disease [10–12]. This evidence concerns the gene KLF4 and von Hippel-Lindau disease.